|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1993-6-14
|
|
pubmed:abstractText |
In vitro studies have demonstrated that a brief exposure of peripherally collected mononuclear cells to high-dose human recombinant interleukin-2(rIL-2) will generate a population of pulsed lymphokine-activated killer (LAK) cells. These cells have similar cytotoxicity against natural killer cells and resistant and sensitive target cells as compared with the standard LAK cells incubated for 3-7 days with rIL-2. Therefore, the authors conducted a pilot study to investigate the activity of pulsed LAK cells in patients with advanced cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3633-9
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8387882-Adult,
pubmed-meshheading:8387882-Aged,
pubmed-meshheading:8387882-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:8387882-Carcinoma, Renal Cell,
pubmed-meshheading:8387882-Colonic Neoplasms,
pubmed-meshheading:8387882-Female,
pubmed-meshheading:8387882-Hong Kong,
pubmed-meshheading:8387882-Humans,
pubmed-meshheading:8387882-Immunotherapy, Adoptive,
pubmed-meshheading:8387882-Interleukin-2,
pubmed-meshheading:8387882-Kidney Neoplasms,
pubmed-meshheading:8387882-Killer Cells, Lymphokine-Activated,
pubmed-meshheading:8387882-Liver Neoplasms,
pubmed-meshheading:8387882-Lung Neoplasms,
pubmed-meshheading:8387882-Male,
pubmed-meshheading:8387882-Melanoma,
pubmed-meshheading:8387882-Middle Aged,
pubmed-meshheading:8387882-Neoplasms,
pubmed-meshheading:8387882-Ovarian Neoplasms,
pubmed-meshheading:8387882-Pilot Projects,
pubmed-meshheading:8387882-Recombinant Proteins,
pubmed-meshheading:8387882-Salivary Gland Neoplasms
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Short-duration in vitro interleukin-2-activated mononuclear cells for advanced cancer. A Hong Kong biotherapy pilot study trial.
|
|
pubmed:affiliation |
Hong Kong Biotherapy Study Group, Hong Kong Sanatorium and Hospital, Happy Valley.
|
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|
